0001567619-21-006400.txt : 20210316 0001567619-21-006400.hdr.sgml : 20210316 20210316161106 ACCESSION NUMBER: 0001567619-21-006400 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210313 FILED AS OF DATE: 20210316 DATE AS OF CHANGE: 20210316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rhodes Jennifer J CENTRAL INDEX KEY: 0001568249 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39990 FILM NUMBER: 21745803 MAIL ADDRESS: STREET 1: C/O ADAMAS PHARMACEUTICALS INC. STREET 2: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Angion Biomedica Corp. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 BUSINESS PHONE: (415) 655-4899 MAIL ADDRESS: STREET 1: 51 CHARLES LINDBERGH BOULEVARD CITY: UNIONDALE STATE: NY ZIP: 11553 4 1 doc1.xml FORM 4 X0306 4 2021-03-13 0 0001601485 Angion Biomedica Corp. ANGN 0001568249 Rhodes Jennifer J C/O ANGION BIOMEDICA CORP. 51 CHARLES LINDBERGH BLVD. UNIONDALE NY 11553 0 1 0 0 See Remarks Common Stock 2021-03-13 4 S 0 499 20.45 D 34286 D The shares were sold to the Issuer solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a Restricted Stock Units ("RSUs") of the Issuer. Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary /s/ Jennifer J. Rhodes 2021-03-16